Diagnosys — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Diagnosys is a long-established leader in ophthalmic electrophysiology, developing and manufacturing high-precision hardware and software systems for visual function testing. Its technology spans from preclinical rodent models (Celeris® system) to clinical diagnostics for humans, serving top-tier academic medical centers and pharmaceutical trials globally. The company's business model integrates product sales with high-value services, including clinical trial setup, training, and data reading, creating a recurring revenue stream from the research and drug development ecosystem.

OphthalmologyNeurology

Technology Platform

Proprietary, fully integrated hardware and software platform for visual electrophysiology. Includes the ColorDome® Ganzfeld stimulator with trillion-to-one luminance range, a 32-bit amplifier for high signal-to-noise resolution, and customizable software. Supports a full suite of tests: electrophysiology (ERG, EOG, VEP), psychophysical, objective acuity, and pupillometry for both preclinical (Celeris® system) and clinical applications.

Opportunities

Growth is driven by the expanding pipeline of gene and cell therapies for retinal diseases, which rely on sensitive electrophysiology endpoints in clinical trials.

Expansion into broader neuroscience applications and biomarker discovery presents a new frontier.

Geographic expansion into emerging markets with growing advanced healthcare infrastructure offers a long-term growth channel.

Risk Factors

Market dependency on niche research and pharmaceutical R&D budgets creates cyclical vulnerability.

Technological disruption from alternative diagnostic modalities is a constant threat.

As a private company, access to large-scale capital for major strategic moves may be limited compared to public entities.

Competitive Landscape

Diagnosys competes in the specialized niche of visual electrophysiology equipment. Key competitors likely include companies like LKC Technologies, Roland Consult, and Elektron. Diagnosys differentiates itself through its claimed technological superiority (e.g., 32-bit amplifier, ColorDome® range), fully integrated platform from preclinical to clinical, and its entrenched, high-value clinical trial services division, which creates a significant barrier to entry and a recurring revenue model.

More companies in Diagnostics & Precision Medicine →More companies in United States →